Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Newly developed compound decreased amyloid pathology and neuroinflammation

Staff Writer
Staff Writer 3 years ago
Updated 2020/05/07 at 7:04 PM
Share
SHARE

Researchers at the University of Illinois tested a new compound in rodents with Alzheimer’s disease and found it profoundly decreased the number of amyloid plaques in the brain. The compound also led to reduced neuroinflammation.

Alzheimer’s disease is one of the most prevalent conditions affecting older adults, with a total diagnosis count in the U.S. close to 6 million, as of 2020.

Published in the peer-reviewed journal ACS Chemical Neuroscience, the study focused on amyloid-beta metal-induced oxidative stress, the accumulation of tau protein, and inflammation in the brain, to identify how they each may affect the onset of neurodegenerative diseases.

Although it is not known the mechanisms that hypothetically result in the onset of neurodegeneration, inhibiting the formation of amyloid plaques has been the subject of vigorous research in past studies. Metal ions are also thought to be a contributing factor in neurodegeneration.


Metal ions bind with the beta-amyloid peptide and are associated with neuroinflammation and damaging oxidative stress among patients with dementia.

In the findings, researchers say they tested a mouse model of Alzheimer’s with a new compound known as L1. The results showed a reduction of amyloid plaques and inflammation in the brain, all characteristic of neurodegeneration.

“When tested in brain cells and in a mouse model of Alzheimer’s disease, a new compound significantly reduced the number of amyloid plaques in the brain, lessened brain inflammation and diminished other molecular markers of the disease,” a U.O.I. news report concluded.

Photo: Shutterstock

You Might Also Like

New study explores test that can detect Alzheimer’s years before diagnosis

New research explores the association between viral infection and Alzheimer’s disease

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

New research finds Alzheimer’s risk factors affect males and females very differently

TAGGED: ventriculomegaly, aging, cognition, dementia
Staff Writer May 7, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article New research reassures effectiveness of cognitive behavioral therapy for treating anxiety among children with autism
Next Article Less people in America believe the media is aggrandizing COVID-19 risks, survey shows

Recommended

Clinical

New study explores test that can detect Alzheimer’s years before diagnosis

1 Min Read
Health

New research explores the association between viral infection and Alzheimer’s disease

1 Min Read
Clinical

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

1 Min Read
Clinical

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?